NormOxys
Latest round
- Series C
Last raised
- May 2010
Total raised
- $23M
Investors
- 2
About NormOxys
NormOxys Inc. is a biotechnology company focused on developing innovative therapeutic solutions to enhance medical treatment and patient outcomes.NormOxys Inc. operates in the biotechnology sector, concentrating on therapeutic solutions for healthcare challenges. The company, headquartered in Wellesley, US, has undergone strategic pivots to enhance its product offerings.NormOxys specializes in advanced therapeutic solutions aimed at addressing specific health challenges in the medical field. The core product offerings include a range of innovative medical devices and treatment protocols designed to enhance patient care and improve clinical outcomes. These products serve a diverse client base, including hospitals, outpatient care facilities, and specialized clinics that focus on chronic disease management. NormOxys's services are tailored to meet the needs of healthcare providers and institutions, offering them effective tools to manage complex patient cases.NormOxys generates revenue through a structured model that incorporates direct sales to healthcare providers and partnerships with distributors in the medical supply sector. The company typically engages in B2B transactions, providing its products directly to hospitals and clinics while also establishing strategic alliances with key stakeholders in the healthcare ecosystem. Pricing plans are aligned with the value offered by their flagship products, ensuring that clients receive optimal solutions for their investment. The revenue from these transactions is reinforced by ongoing support services that accompany product sales, solidifying long-term relationships with customers and enhancing client retention.NormOxys plans to enhance its product line with new medical devices designed to address unmet healthcare needs, with potential launches slated for the upcoming year.6 million to support these initiatives. This strategic expansion is designed to strengthen its market presence and enhance service delivery to healthcare providers.
Who invested in NormOxys
2 investors across 2 rounds
See all investors in NormOxys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NormOxys
Who invested in NormOxys?
NormOxys has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NormOxys raised?
NormOxys has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NormOxys last raise money?
NormOxys's most recent round on record is a Series C, in May 2010.
What does NormOxys do?
NormOxys is a biotechnology company.
Where is NormOxys headquartered?
NormOxys is headquartered in Wellesley, US.
Which VCs invest in companies like NormOxys?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NormOxys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like NormOxys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.